Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2025-12-25 @ 7:11 PM
NCT ID: NCT05494632
Description: Adverse events were not formally collected during this study. However, all-cause mortality and serious adverse were monitored due to the fact that the participants came to a number of test sessions and the researchers would have been aware if a serious adverse event would have occurred. No serious adverse events took place during this study.
Frequency Threshold: 0
Time Frame: Adverse events were collected over a period of approximately 16 weeks for each group.
Study: NCT05494632
Study Brief: Interaural Frequency and Loudness Mismatch in SSD CI Users
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Period 1: Study 1 Twenty experienced single-sided deaf cochlear implant recipients (SSD-CI) compared their everyday speech processor program frequency allocation table (FAT) to a modified FAT. The modified FAT was created to reduce interaural frequency mismatch between the normal hearing ear and the cochlear implant ear. Participants were first tested with their everyday FAT. They were tested a second time after 6 weeks use of the modified FAT. Lastly, they compared both FATs on their speech processor at home for several weeks, after which they were tested a second time with each FAT. 0 None 0 20 0 20 View
Period 2: Study 2 Ten newly implanted single-sided deaf cochlear implant recipients (SSD-CI) participated. They compared the manufacturer's default FAT to a modified FAT. The modified FAT was created to reduce interaural frequency mismatch between the normal hearing ear and the cochlear implant ear. Five participants were assigned the manufacturer's default FAT at initial activation. Five were assigned to the modified FAT at initial activation. After 6 weeks use of the default or modified FAT, participants were tested and then began using the FAT that they had not been using, for another 6 weeks. Participants were tested again at the end of six weeks. They were tested a third time after comparing both FATs for several weeks. 0 None 0 10 0 10 View
Period 3: Study 3 Fifteen experienced SSD-CI recipients compared their everyday speech processor program to a modified loudness speech processor program. The modified loudness program was created in an attempt to balance loudness between the normal hearing ear and the cochlear implant ear and therefore decrease interaural loudness mismatch. Participants were first tested with their everyday program. They were tested a second time after 6 weeks use of the modified program. Lastly, they compared both programs on their speech processor at home for several weeks, after which they were tested a second time with each program. 0 None 0 15 0 15 View
Serious Events(If Any):
Other Events(If Any):